S. Bertil Olsson - Concepedia

Author

S. Bertil Olsson

Also Known As

Olsson, S., S B Olsson, S B. OLSSON, S Bertil Olsson, S Olsson, S. B. OLSSON, S. B. Olsson, S. BERTIL OLSSON, S. Bertil OLSSON, S. Bertil Olsson

179

Publications

8.7K

Citations

H-Index

Concepts

All Affiliations

Lund University Sahlgrenska University Hospital University Hospital Magdeburg

About

S. Bertil Olsson is an author at Lund University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	36	3.3K
2	Public Health	17	19	2K
3	Social Sciences	4	4	79
4	Engineering	3	3	243
5	Health Sciences	2	2	82

S. Bertil Olsson

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI Matthias Götberg, Evald Høj Christiansen, Ingibjörg Jóna Guðmundsdóttir, New England Journal of Medicine	2017	937
Atrial fibrillation management: a prospective survey in ESC Member Countries Robby Nieuwlaat, Alessandro Capucci, A. John Camm, European Heart Journal	2005	822
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial S. Bertil Olsson The Lancet ThrombosisIschemic StrokeCardiovascular DiseaseMedicineNon-valvular Atrial Fibrillation	2003	810
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation Gregory W. Albers, Hans‐Christoph Diener, Lars Frison, JAMA	2005	662
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Valentı́n Fuster, Lars Rydén, David S. Cannom, Journal of the American College of Cardiology ThrombosisCardiac AnaesthesiaAcc/aha/esc 2006Cardiovascular DiseasePatient Safety	2006	467
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran) L. Samüel Wann, Anne B. Curtis, Kenneth A. Ellenbogen, Heart Rhythm ThrombosisCardiovascular DiseasePatient SafetyCardiovascular PharmacologyPharmacotherapy	2011	398
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation Robby Nieuwlaat, S. Bertil Olsson, Gregory Y.H. Lip, American Heart Journal ThrombosisGuideline-adherent Antithrombotic TreatmentCardiovascular DiseasePatient SafetyOutcomes Research	2007	205
A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Carina Blomström‐Lundqvist, K.‐G. SABEL, S. Bertil Olsson Heart Heart FailureStructural Heart DiseaseDiastolic FunctionRight Ventricular TachycardiaPublic Health	1987	192
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Valentı́n Fuster, Lars Rydén, David S. Cannom, European Heart Journal	2007	185
Sequential Characterization of Atrial Tachyarrhythmias Based on ECG Time-Frequency Analysis Martin Stridh, L. Sörnmo, Carl Meurling, IEEE Transactions on Biomedical Engineering EngineeringSpectrum EstimationAtrial Fibrillation FrequencyElectrophysiological EvaluationEcg Time-frequency Analysis	2004	148

Page 1